BlackRock, Inc. 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-17 09:35 am Sale |
2025-03-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
6,274,384 8.000% |
-1,394,487![]() (-18.18%) |
Filing |
2024-01-08 4:35 pm Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
7,668,871 10.200% |
1,028,017![]() (+15.48%) |
Filing |
2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
6,640,854 9.200% |
250,913![]() (+3.93%) |
Filing |
2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
6,389,941 9.000% |
361,822![]() (+6.00%) |
Filing |
2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
6,028,119 8.800% |
1,113,526![]() (+22.66%) |
Filing |